Feed additive for improving production performance of weaned piglets

The plant essential oils treated through microcapsule coating technology use 'oil + water' double coating and shellac film to achieve sustained release of plant essential oils at the back end of the digestive tract, solving the decline in growth performance and intestinal barriers during weaning of piglets The injury problem significantly improves the health and immunity of piglets.

CN119033030AInactive Publication Date: 2024-11-29INST OF ANIMAL HUSBANDRY & VETERINARY MEDICINE JIANGXI ACAD OF AGRI SCI +1

Patent Information

Application Number
CN202411226626.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-03
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Piglets face problems with undeveloped digestive function, low immunity, decreased growth performance, diarrhea and intestinal barrier damage caused by psychological and environmental changes. The existing use of antibiotics leads to safety of livestock products and bacterial resistance, and antibiotic replacement is needed. to alleviate these problems.

Method used

Using microcapsule coating technology to treat plant essential oils, through innovative capsule wall materials and structural design, a double-layer coating of 'oil + water' is formed, combined with shellac film, the sustained release of plant essential oils is achieved effectively at the back end of the digestive tract and reduce stimulation. Sexual odor and volatile losses.

Benefits of technology

Improve the growth performance, intestinal health, immunity and antioxidant properties of weaned piglets, reduce diarrhea rate and meat-filled ratio, enhance intestinal barrier function and digestive enzyme activity, reduce endotoxin release, and significantly improve piglets' Overall health.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005024776900000041
    Figure BDA0005024776900000041
  • Figure BDA0005024776900000051
    Figure BDA0005024776900000051
  • Figure BDA0005024776900000091
    Figure BDA0005024776900000091
Patent Text Reader

Abstract

The invention discloses a feed additive for improving the production performance of weaned piglets, and belongs to the technical field of feed additives. The dosage form of the feed additive for improving the production performance of the weaned piglets is micro-capsules. The plant essential oil capsule comprises the following components in percentage by mass: a capsule material: 10-15% of plant essential oil, and a capsule wall material: an inner layer comprises 15-20% of dextrin and 25-30% of starch, and an outer layer comprises 25-30% of hydrogenated plant oil and 15-20% of shellac. According to the plant essential oil sustained-release microcapsule disclosed by the invention, the structure and components of the capsule wall are designed, the plant essential oil is wrapped in the form of'oil + water 'of the capsule wall, and the shellac component is added into the capsule wall material, so that the volatile odor of the plant essential oil is fully masked, the possibility that the microcapsule is digested in the stomach to release the plant essential oil is reduced, and the plant essential oil sustained-release microcapsule is released and absorbed in the intestinal tract; the influence of pungent odor on piglet ingestion is reduced, the intestinal health of weaned piglets is improved, and the growth performance of the weaned piglets is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of feed additives, and in particular relates to a feed additive for improving the production performance of weaned piglets. Background Art

[0002] Early weaning of piglets is one of the key technologies in the intensive pig production process. After weaning, the digestive function of piglets is not fully developed, the immune function is low, and they are also facing changes in psychological, environmental, nutritional and other factors. They are prone to "piglet weaning syndrome", which is mainly manifested by decreased feed intake, insufficient secretion of endogenous digestive enzymes, low feed utilization, weakened metabolic intensity, disordered intestinal environment, and decreased ability to resist diseases, which may eventually lead to disease or even death. In order to solve a series of problems caused by piglet weaning stress, a large amount of antibiotics are often added in actual production to prevent or treat intestinal barrier damage caused by weaning stress. In recent years, the abuse of antibiotics has led to increasingly prominent problems such as livestock product safety and bacterial resistance. Therefore, it is urgent to find efficient antibiotic substitutes to alleviate the problems of decreased growth performance, diarrhea and intestinal barrier damage caused by piglet weaning stress, which is of great significance to the healthy and sustainable development of the pig industry. Summary of the invention

[0003] The purpose of the present invention is to provide a feed additive for improving the production performance of weaned piglets. The plant essential oil is processed by microencapsulation technology, and the capsule wall material and structure are innovatively designed, so that the encapsulated plant essential oil has no irritating odor and is more accurately released at the rear end of the digestive tract, thereby achieving the effect of better improving the production performance of weaned piglets.

[0004] To achieve the above object, the present invention provides the following technical solutions:

[0005] One of the technical solutions of the present invention is to provide a feed additive for improving the production performance of weaned piglets, the dosage form is a microcapsule; the components, by mass percentage, include: capsule core material: 10-15% plant essential oil, capsule wall material: inner layer: 15-20% dextrin and 25-30% starch, outer layer: 25-30% hydrogenated vegetable oil and 15-20% shellac flakes.

[0006] Preferably, the thymol content in the plant essential oil is ≥13.5wt.%, and the cinnamaldehyde content is ≥6.5wt.%.

[0007] The second technical solution of the present invention is to provide a method for preparing the feed additive for improving the production performance of weaned piglets, the steps comprising:

[0008] Dissolve dextrin and starch in water, add plant essential oil, disperse them to form an oil-in-water coating structure, homogenize them, and then perform preliminary spray drying to obtain pre-encapsulated microcapsules; mix hydrogenated vegetable oil and shellac flakes and heat and melt them, spray the pre-encapsulated microcapsules from an upper normal temperature nozzle to a low-temperature drying chamber, and then spray the molten mixture of hydrogenated vegetable oil and shellac flakes to the low-temperature drying chamber from a heated nozzle below the normal temperature nozzle, mix them evenly under the action of airflow to form solid microcapsules, and sieve them to obtain a feed additive for improving the production performance of weaned piglets.

[0009] Preferably, the heating and melting temperature is 80-85°C.

[0010] Preferably, the sieving is through a 20-mesh sieve.

[0011] The third technical solution of the present invention is to provide an application of the above-mentioned feed additive for improving the production performance of weaned piglets in feed additives for weaned piglets.

[0012] Plant essential oils have poor stability and are sensitive to factors such as air, light, and temperature. They are easily volatile and easily oxidized and deteriorated under natural conditions, which greatly increases the difficulty of storage and processing, and their application in the breeding industry is also greatly limited. On the one hand, the active ingredients of plant essential oils are easy to deteriorate during feed processing and storage, and have a pungent odor, which affects piglets' feeding; on the other hand, the components of plant essential oils are quickly absorbed in the stomach and the front part of the small intestine, and the effective ingredients that can reach the back end of the intestinal cavity to interact with the flora are greatly reduced, thereby reducing the effect of plant essential oils. In order to overcome the defects of plant essential oils used as feed additives, microencapsulation is obviously one of the effective means.

[0013] Microencapsulation technology mainly uses special wall capsule materials and coating processes to encapsulate the components of plant essential oils in microcapsules, isolating them from the external environment to maintain the activity of the active ingredients and reduce irritating odors. It not only facilitates storage, transportation and use, but also can achieve targeted release in the digestive tract, allowing the active ingredients of the product to effectively reach the back end of the digestive tract.

[0014] The beneficial technical effects of the present invention are as follows:

[0015] The present invention designs the capsule wall structure and components, wraps the plant essential oil in the "oil + water" double-layer form of the capsule wall and adds shellac flake components to the capsule wall material, thereby fully masking the volatile odor of the plant essential oil, reducing the possibility of the microcapsule being digested in the stomach and releasing the plant essential oil, allowing the plant essential oil sustained-release microcapsules to be released and absorbed in the intestine, thereby reducing the impact of the irritating odor on the feeding of piglets, improving the intestinal health of weaned piglets, and improving their growth performance. DETAILED DESCRIPTION

[0016] Now, various exemplary embodiments of the present invention are described in detail, and this detailed description should not be considered as a limitation of the present invention, but should be understood as a more detailed description of certain aspects, characteristics and embodiments of the present invention. It should be understood that the terms described in the present invention are only for describing specific embodiments and are not used to limit the present invention.

[0017] In addition, for the numerical range in the present invention, it is understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0018] Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the invention pertains. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the present invention.

[0019] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0020] The plant essential oils used in the examples and comparative examples of the present invention are all plant essential oils containing 15 wt.% of thymol and 8 wt.% of cinnamaldehyde.

[0021] Example 1

[0022] Preparation of plant essential oil sustained-release microcapsules:

[0023] 0.15 kg of dextrin and 0.25 kg of starch were dissolved in 0.3 kg of purified water, and then 0.15 kg of plant essential oil was added, dispersed with a high-speed disperser to form an oil-in-water coating structure, and then homogenized with a high-pressure homogenizer, and spray-dried with an airflow spray dryer after homogenization to obtain pre-encapsulated microcapsules;

[0024] 0.25 kg of hydrogenated vegetable oil and 0.2 kg of shellac flakes were mixed and melted at 80°C. The pre-packaged microcapsules were sprayed from the upper normal temperature nozzle into the low temperature drying chamber. Then, the mixture of the molten hydrogenated vegetable oil and shellac flakes was sprayed into the low temperature drying chamber from the heated nozzle below the normal temperature nozzle. The two were evenly mixed under the action of airflow to form solid microcapsules, which were passed through a 20-mesh sieve to obtain plant essential oil sustained-release microcapsules (denoted as MCEO-1).

[0025] Comparative Example 1

[0026] Preparation of plant essential oil microcapsules:

[0027] Mix 0.47 kg of hydrogenated vegetable oil and 0.38 kg of shellac flakes, melt at 80°C, then add 0.15 kg of plant essential oil, stir evenly and spray into a low-temperature drying chamber through a heated nozzle to form solid microcapsules. Pass through a 20-mesh sieve to obtain plant essential oil microcapsules (denoted as MCEO-2).

[0028] Comparative Example 2

[0029] Preparation of plant essential oil microcapsules:

[0030] Take 0.85 kg of hydrogenated vegetable oil, melt it at 80°C, then add 0.15 kg of plant essential oil, stir evenly and spray it into a low-temperature drying chamber through a heated nozzle to form solid microcapsules. Pass them through a 20-mesh sieve to obtain plant essential oil microcapsules (denoted as MCEO-3).

[0031] Experimental Design:

[0032] 120 healthy, 30-day-old weaned Tibetan piglets with similar body weight were selected. After 3 days of pre-feeding, they were randomly divided into 5 groups (the initial body weight differences among the groups were not significant), with 4 replicates in each group and 6 pigs in each replicate. They were fed with basal diet (NC), basal diet supplemented with 100 mg / kg kitasamycin premix (effective dose 10 mg / kg) and 500 mg / kg colistin sulfate premix (effective dose 50 mg / kg) (PC), basal diet supplemented with 1.5 g / kg MCEO-1 (MCEO-1, effective dose of plant essential oil is 225 mg / kg), basal diet supplemented with 1.5 g / kg MCEO-2 (MCEO-2, effective dose of plant essential oil is 225 mg / kg), and basal diet supplemented with 1.5 g / kg MCEO-3 (MCEO-3, effective dose of plant essential oil is 225 mg / kg). The experimental groups are shown in Table 1. The pre-test period was 3 days and the main test period was 32 days. The nutritional level of the basic diet (corn and soybean meal type) was prepared according to the NRC (2012) standard for pig nutrition requirements. The piglets were allowed to eat and drink freely, and the total feed intake was recorded. The health status of the piglets was observed daily. The experimental pigs were strictly managed and immunized according to the routine management procedures and immunization procedures of the pig farm.

[0033] Table 1 Test groups

[0034]

[0035]

[0036] Feeding and management:

[0037] Before the test, the test pens were flushed and fully disinfected. All the test pigs were kept in the same pig house with consistent conditions, good ventilation and lighting conditions, and were cleaned daily to keep the pens clean. The test pigs were allowed to eat and drink freely, were fed twice a day, and the diarrhea and health status of the piglets were observed.

[0038] Sample collection:

[0039] After the experiment, two pigs with a weight close to the average weight of the replicate were selected from each repetition for blood sampling from the anterior vena cava, and serum was separated for the determination of relevant serum biochemical indices. One pig was selected from each repetition for slaughter (a total of 20 pigs) and the small intestine segments were stripped. The small intestine was cut longitudinally along the mesentery to determine the pH value of the intestinal contents of each segment; one portion of the contents of each segment was taken for the detection of digestive tract enzyme activity; about 1 cm of each segment was taken, fixed with paraformaldehyde, and HE and PAS staining were performed for intestinal tissue morphology observation and goblet cell counting; another 10 cm of each segment was taken, the intestinal contents were gently rinsed with saline, the water was absorbed with filter paper, and the intestinal mucosa was gently scraped with the blunt side of a scalpel, and the intestinal mucosa was divided into 5 mL sterile cryopreservation tubes, quick-frozen in liquid nitrogen, and stored at -80 ° C to test the expression of intestinal tight junction proteins; about 1 g of ileal contents was taken aseptically for intestinal microbial determination.

[0040] Growth performance and diarrhea rate determination:

[0041] Each piglet was weighed on an empty stomach one day before the start and end of the experiment, and the average daily weight gain (ADG) was calculated; the feed consumption during the experiment was recorded, and the average daily feed intake (ADFI) and feed-to-weight ratio (F / G) were calculated. The feces of the experimental pigs were observed every day during the experiment, and the diarrhea was determined by feces scoring, 0 points: feces strips or granules; 1 point: soft feces, can be formed; 2 points: thick, unformed, feces and water are not separated; 3 points: liquid, unformed, feces and water are separated. 2 and 3 points are recorded as diarrhea. The diarrhea rate of piglets is calculated by pen. Diarrhea rate (%) = total number of piglet diarrhea / (total number of experimental piglets × number of days in the trial period) × 100.

[0042] Serum index determination:

[0043] Biochemical indicators related to protein metabolism: total protein (TP), albumin (ALB), globulin (GLB), serum urea nitrogen (Urea). They were measured using kits purchased from Nanjing Jiancheng Biological Research Institute and Sinopharm Biotechnology Co., Ltd.

[0044] Biochemical indices related to fat metabolism: total cholesterol (TC), triglyceride (TG) and other indicators were detected by colorimetry on a Mindray BS-420 fully automatic biochemical analyzer (Shenzhen Mindray Bio-Medical Electronics Co., Ltd.).

[0045] Biochemical indicators related to liver function: alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) were detected using test kits purchased from Sinopharm Beijing Enterprises Co., Ltd.

[0046] Indicators related to piglet immunity: Immunoglobulin A (IgA), Immunoglobulin G (IgG) and Immunoglobulin M (IgM). Purchase the test kit from Shanghai Jining Industrial Co., Ltd.

[0047] Related inflammatory factor indicators: lipopolysaccharide (LPS), anti-inflammatory factors, interleukin 4 (IL-4), interleukin 10 (IL-10); pro-inflammatory factors, interleukin 1β (IL-1β), tumor necrosis factor α (TNF-α), interferon γ (IFN-γ), etc. were determined using kits purchased from Nanjing Jiancheng Biological Research Institute and Sinopharm Biotechnology Co., Ltd.

[0048] Hormone indicators related to growth and metabolism: insulin-like growth factor-1 (IGF-1), triiodothyronine (T3), and thyroxine (T4). They were measured using kits purchased from Tianjin Jiuding Biotechnology Co., Ltd.

[0049] Intestinal barrier function assay:

[0050] Intestinal physical barrier function: Observation and determination of intestinal mucosal morphology and structure: HE staining, determination of villus height (VH), crypt depth (CD), and villus length / crypt depth (V / C) of each segment of the small intestine. Determination of endotoxin content in the intestine: determination by kit, purchased from Shanghai Bogu Biotechnology Co., Ltd. Detection of intestinal tight junction protein expression: Real-time fluorescence RT-PCR was used to determine the expression levels of occludens (Occludin), tight junction protein (Claudin-2), and zonula occludens 1 (ZO-1) in the mucosa of each segment of the small intestine.

[0051] Intestinal chemical barrier function: pH measurement of intestinal contents. Determination of small intestinal mucopolysaccharide secretion: PAS staining, measurement of small intestinal villus epithelial length (VEL), counting of goblet cells (GCC) in each segment of the small intestine, and calculation of the number of goblet cells per unit villus length (GCC / VEL). Determination of digestive enzyme activity of small intestinal contents in each segment: lipase, lactase, sucrase, maltase, trypsin, and amylase were determined using kits purchased from Nanjing Jiancheng Biological Research Institute and Sinopharm Biotechnology Co., Ltd.

[0052] Intestinal immune barrier function: mRNA expression of ileal mucosa-related inflammatory factors. Real-time fluorescence quantitative RT-PCR was used to detect the expression of anti-inflammatory factors IL-4 and IL-10, and pro-inflammatory factors: IL-1β, TNF-α, and IFN-γ.

[0053] Test results and analysis

[0054] 1. Effects of different treatments on growth performance of weaned piglets

[0055] The results of the growth performance of weaned piglets are shown in Table 2.

[0056] Table 2 Effects of different treatments on growth performance of weaned piglets

[0057] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Initial weight / kg 5.21 5.20 5.22 5.21 5.21 Final weight t / kg <![CDATA[12.43 c ]]> <![CDATA[12.58 a ]]> <![CDATA[12.58 a ]]> <![CDATA[12.55 a ]]> <![CDATA[12.50 b ]]> Average daily feed intake ADFI / (g / d) 451.92 454.52 459.96 453.07 452.18 Average daily gain ADG / (g / d) <![CDATA[225.47 b ]]> <![CDATA[230.39 a ]]> <![CDATA[230.16 a ]]> <![CDATA[229.45 a ]]> <![CDATA[227.66 ab ]]> Material weight ratio F / G 2.00 1.97 1.98 1.97 1.99 Diarrhearate / % <![CDATA[5.23 a ]]> <![CDATA[2.55 c ]]> <![CDATA[3.09 b ]]> <![CDATA[4.29 b ]]> <![CDATA[4.61 b ]]>

[0058] Note: Data without letters or the same letters in the same row indicate no significant difference (P>0.05), and different lowercase letters indicate significant difference (P<0.05).

[0059] As shown in Table 2, compared with the control group, adding antibiotics or different preparations of plant essential oils to the diet of weaned piglets significantly reduced the diarrhea rate of piglets and significantly increased the final weight of piglets. MCEO-1 and MCEO-2 significantly increased the average daily weight gain of piglets. There was no significant difference in feed intake and feed-to-weight ratio among the experimental groups.

[0060] 2. Protein metabolism related indicators

[0061] The results of the determination of protein metabolism related indicators are shown in Table 3.

[0062] Table 3 Effects of different treatments on protein metabolism in weaned piglets

[0063] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Total protein TP / (g / L) <![CDATA[41.99 c ]]> <![CDATA[49.00 ab ]]> <![CDATA[50.72 a ]]> <![CDATA[46.76 abc ]]> <![CDATA[43.10 bc ]]> Albumin ALB / (g / L) 17.36 20.22 27.23 24.00 22.64 Globulin GLB / (g / L) 23.09 25.25 30.29 29.20 28.86 Urea nitrogen (mmol / L) 3.37 2.83 2.61 2.96 2.76

[0064] As can be seen from Table 3, after adding different preparations of plant essential oils to the diet, the serum total protein, albumin and globulin concentrations of weaned piglets increased compared with the control group, especially in the MCEO-1 group, where the total protein was significantly higher than that of the non-antibiotic control group, and significantly different from the antibiotic control group. The albumin and globulin concentrations of the MCEO-1 group were 56.9% and 31.2% higher than those of the non-antibiotic control group, and 34.7% and 20.0% higher than those of the antibiotic control group. The Urea concentration of the MCEO-1 group was 22.6% and 7.8% lower than that of the control group and the antibiotic group, respectively. This indicates that the plant essential oil microcapsules pre-packaged with dextrin + starch and encapsulated with shellac flakes in hydrogenated vegetable oil have obvious advantages over the plant essential oil microcapsules that are not pre-packaged and the plant essential oil microcapsules that are not pre-packaged and do not add shellac flakes, which can promote the synthesis of protein in weaned piglets to a certain extent and keep the metabolic level and immune function of young animals in a good state.

[0065] 3. Fat metabolism related indicators

[0066] The results of the determination of fat metabolism related indicators are shown in Table 4.

[0067] Table 4 Effects of different treatments on fat metabolism in weaned piglets

[0068] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Total cholesterol TC / (mmol / L) 1.82 1.59 1.45 1.70 1.66 Triglyceride TG / (mmol / L) 0.53 0.45 0.42 0.48 0.47

[0069] It can be seen from Table 4 that after adding different preparations of plant essential oils to the feed, there was no significant difference in the serum triglyceride and total cholesterol levels of piglets compared with the control group, indicating that adding different preparations of plant essential oils does not affect lipid metabolism in piglets.

[0070] 4. Liver function related indicators

[0071] The results of liver function related indicators are shown in Table 5.

[0072] Table 5 Effects of different treatments on liver function of weaned piglets

[0073] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Aspartate transaminase AST / (U / L) 45.63 41.78 40.10 42.29 43.15 Alanine transaminase (ALT) / (U / L) 34.33 33.82 32.65 31.77 33.11 Alkaline phosphatase ALP (U / L) 149.99 168.35 160.29 175.74 158.66

[0074] As can be seen from Table 5, adding different preparations of plant essential oils to the diet has no significant effect on the activities of serum aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase in weaned piglets, indicating that adding different preparations of plant essential oils will not have adverse effects on the liver function of the body.

[0075] 5. Immune-related indicators

[0076] The results of the determination of immune-related indicators are shown in Table 6.

[0077] Table 6 Effects of different treatments on immune function of weaned piglets

[0078]

[0079] As can be seen from Table 6, different preparations of plant essential oils significantly increased the serum IgG content, among which the MCEO-1 group had the highest IgG content, which increased by 8.1% and 8.7% compared with the MCEO-2 and MCEO-3 groups, respectively. The serum IgM content of the MCEO-1 group was significantly higher than that of the non-antibiotic control group and the antibiotic control group, which increased by 16.5% and 13.1% compared with the MCEO-2 and MCEO-3 groups, respectively. It can be seen that MCEO-1 has a certain promoting effect on the immunity of weaned piglets, and its effect is better than that of MCEO-2 and MCEO-3.

[0080] 6. Inflammatory response related indicators

[0081] The results of the determination of inflammatory response related indicators are shown in Table 7.

[0082] Table 7 Effects of different treatments on serum inflammatory factors in weaned piglets

[0083] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Serum endotoxin LPS / (EU / mL) <![CDATA[0.58 a ]]> <![CDATA[0.54 a ]]> <![CDATA[0.42 b ]]> <![CDATA[0.46 b ]]> <![CDATA[0.47 b ]]> Interferon γIFNγ / (pg / mL) <![CDATA[50.13 a ]]> <![CDATA[48.72 a ]]> <![CDATA[40.13 b ]]> <![CDATA[42.25 b ]]> <![CDATA[42.69 b ]]> Interleukin-1βIL-1β / (pg / mL) <![CDATA[34.03 a ]]> <![CDATA[31.20 ab ]]> <![CDATA[28.65 b ]]> <![CDATA[31.14 ab ]]> <![CDATA[29.88 ab ]]> Tumor necrosis factor αTNFα / (pg / mL) 64.68 62.52 55.39 59.78 60.41 Interleukin 4IL-4 / (pg / mL) <![CDATA[7.20 b ]]> <![CDATA[7.53 b ]]> <![CDATA[9.76 a ]]> <![CDATA[8.76 ab ]]> <![CDATA[8.55 ab ]]> Interleukin 10IL-10 / (pg / mL) <![CDATA[13.12 c ]]> <![CDATA[15.30 bc ]]> <![CDATA[20.01 a ]]> <![CDATA[17.68 ab ]]> <![CDATA[16.92 a ]]>

[0084] As can be seen from Table 7, compared with the non-antibiotic control group and the antibiotic control group, the plant essential oil preparation group significantly reduced the serum endotoxin content of weaned piglets, among which the endotoxin content of the MCEO-1 group was the lowest, which was 8.7% and 10.6% lower than that of the MCEO-2 group and the MCEO-3 group, respectively. It can be seen that the effect of the plant essential oil has been significantly improved by the preparation process of plant essential oil sustained-release microcapsules that are pre-packaged with dextrin + starch and then coated with shellac sheets in hydrogenated vegetable oil. It can regulate intestinal microorganisms, reduce intestinal endotoxin release, maintain the selective permeability of the intestinal mucosal barrier, and reduce the absorption of endotoxin into the blood, thereby reducing the incidence of diarrhea, edema and shock caused by endotoxin in piglets.

[0085] Compared with the non-antibiotic control group and the antibiotic control group, the addition of plant essential oil preparations significantly reduced the γIFN concentration in the serum of weaned piglets, among which the MCEO-1 group had the lowest γIFN concentration; MCEO-1 significantly reduced the IL-1β concentration in the serum; the TNFα in the blood of weaned piglets in the plant essential oil preparation group showed a downward trend; MCEO-1 significantly increased the IL-4 and IL-10 concentrations in the serum. This indicates that the plant essential oil sustained-release microcapsules pre-packaged with dextrin + starch and then coated with shellac sheets in hydrogenated vegetable oil can reduce the secretion of pro-inflammatory factors in weaned piglets and increase the level of anti-inflammatory factors, thereby reducing the infiltration of inflammatory cells and improving tissue damage.

[0086] 7. Related hormone indicators

[0087] The results of the determination of relevant hormone indicators are shown in Table 8.

[0088] Table 8 Effects of different treatments on growth hormone in weaned piglets

[0089]

[0090] As can be seen from Table 8, compared with the antibiotic control group and the non-antibiotic control group, MCEO-1, MCEO-2 and MCEO-3 significantly increased the serum IGF-1 concentration of weaned piglets; compared with the non-antibiotic control group, antibiotic control group, MCEO-2 group and MCEO-3 group, the T3 concentration of MCEO-1 group increased by 11.8%, 9.6%, 3.6% and 5.6%, respectively, and the T4 concentration increased by 5.5%, 5.2%, 0.1% and 2.3%, respectively. The results show that the plant essential oil sustained-release microcapsules pre-packaged with dextrin + starch and then coated with shellac sheets in hydrogenated vegetable oil can improve growth performance and promote body growth by regulating the hormone level in the body of weaned piglets, and relieve the weaning stress of piglets to a certain extent.

[0091] 8. Effects of different treatments on intestinal barrier function in weaned piglets

[0092] The results of the determination of the intestinal morphology of weaned piglets are shown in Table 9.

[0093] Table 9 Effects of different treatments on intestinal morphology of weaned piglets

[0094]

[0095] It can be seen from Table 9 that compared with the antibiotic control group and the non-antibiotic control group, the plant essential oil preparation increased the intestinal villus height and villus height / crypt in different intestinal segments to a certain extent.

[0096] 9. Intestinal endotoxin content

[0097] The results of intestinal endotoxin content determination are shown in Table 10.

[0098] Table 10 Effects of different treatments on intestinal endotoxin (LPS) in weaned piglets

[0099] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Duodenum (EU / mg.pro) <![CDATA[0.36 a ]]> <![CDATA[0.34 ab ]]> <![CDATA[0.26 d ]]> <![CDATA[0.29 cd ]]> <![CDATA[0.31 bc ]]> Jejunum (EU / mg.pro) 0.34 0.32 0.30 0.31 0.31 Ileum (EU / mg.pro) 0.28 0.26 0.23 0.23 0.24

[0100] As can be seen from Table 10, compared with the non-antibiotic control group, the plant essential oil preparation significantly reduced the endotoxin content in the duodenum. The endotoxin content in the MCEO-1 group was the lowest, significantly lower than the antibiotic control group and the MCEO-2 group, and decreased by 10.3% and 16.1% compared with the MCEO-2 group and the MCEO-3 group, respectively. The endotoxin content in the jejunum of weaned piglets in the plant essential oil preparation group showed a downward trend compared with the non-antibiotic control group and the antibiotic control group, with the MCEO-1 group being the lowest, and decreasing by 11.8%, 6.3%, 3.2% and 3.2% respectively relative to the non-antibiotic control group, the antibiotic control group, the MCEO-2 group and the MCEO-3 group. There was no significant difference in the ileum endotoxin content among the groups, with the MCEO-1 group and the MCEO-2 group being the lowest, and decreasing by 17.9%, 11.5% and 4.2% respectively relative to the non-antibiotic control group, the antibiotic control group and the MCEO-3 group. It can be seen that plant essential oils can improve the massive reproduction and endotoxin release of pathogens in the intestines of piglets after weaning. The antibacterial effect of plant essential oils can be improved to a certain extent by pre-packaging with dextrin + starch and adding shellac flakes to hydrogenated vegetable oil.

[0101] 10. Intestinal tight junction proteins

[0102] The results of the determination of intestinal tight junction proteins are shown in Table 11.

[0103] Table 11 Effects of different treatments on intestinal tight junction proteins in weaned piglets

[0104]

[0105] As can be seen from Table 11, MCEO-1 can significantly upregulate the expression of OCLN and ZO-1 in the duodenum. MCEO-1 and MCEO-2 can significantly upregulate the expression of ZO-1 in the jejunum, among which the expression of MCEO-1 is higher than that of the MCEO-2 group. MCEO-1 and MCEO-3 significantly upregulate the expression of CLDN2 in the jejunum, and MCEO-2 significantly upregulates the expression of OCLN in the jejunum. Compared with PC, MCEO-1 and MCEO-3 significantly upregulate the expression of OCLN in the ileum, and different plant essential oil preparations have no significant effect on the expression of CLDN2 and ZO-1 in the ileum. It can be seen that plant essential oils can upregulate the expression of tight junction proteins in the small intestine, thereby maintaining the integrity of the intestinal mucosal barrier, among which MCEO-1 has the best effect.

[0106] 11. Intestinal epithelial secretory cells

[0107] The results of the determination of intestinal epithelial secretory cells are shown in Table 12.

[0108] Table 12 Effects of different treatments on intestinal epithelial secretory cells in weaned piglets

[0109]

[0110] As can be seen from Table 12, MCEO-1 significantly increased the length of the villus epithelium and the number of goblet cells in the duodenum. The number of goblet cells per unit epithelial length increased by 54.1%, 33.8%, 25.8% and 27.1% compared with the non-antibiotic control group, antibiotic control group, MCEO-2 group and MCEO-3 group, respectively. Different plant essential oil preparations have a certain promoting effect on the epithelial length and goblet cell number of the jejunum and ileum, but there is no significant difference with the control group. The results show that MCEO-1 can increase the length of the villus epithelium and the number of goblet cells in the duodenum, thereby promoting the secretion of mucin in the intestine, ensuring the intestinal chemical barrier function of weaned piglets, and helping to reduce the permeability of the small intestinal mucosa, thereby effectively maintaining the body's normal nutrient digestion and absorption function and reducing the damage of pathogenic microorganisms to the intestine.

[0111] 12. Intestinal pH

[0112] The results of intestinal pH determination are shown in Table 13.

[0113] Table 13 Effects of different treatments on intestinal pH of weaned piglets

[0114] project Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Duodenum <![CDATA[6.02 a ]]> <![CDATA[6.00 a ]]> <![CDATA[5.58 b ]]> <![CDATA[5.82 a ]]> <![CDATA[5.90 a ]]> jejunum <![CDATA[6.37 a ]]> <![CDATA[6.48 a ]]> <![CDATA[5.88 b ]]> <![CDATA[5.99 b ]]> <![CDATA[6.35 a ]]> Ileum 6.82 7.04 6.58 6.86 6.96

[0115] As can be seen from Table 13, compared with the non-antibiotic control group and the antibiotic control group, MCEO-1 significantly reduced the duodenal pH of weaned piglets, and the plant essential oil sustained-release microcapsules significantly reduced the jejunal pH, among which the jejunal pH of the MCEO-1 group was lower.

[0116] 13. Pig intestinal digestive enzyme activity

[0117] The results of the determination of pig intestinal digestive enzyme activity are shown in Table 14.

[0118] Table 14 Effects of different treatments on intestinal digestive enzymes in weaned piglets

[0119]

[0120] As shown in Table 14, different plant essential oil preparations increased the digestive enzyme activities of each intestinal segment to a certain extent. The duodenal lipase activity of the MCEO-1 group was significantly higher than that of the antibiotic control group, the non-antibiotic control group and the MCEO-2 group, and the sucrase activity was significantly higher than that of the non-antibiotic control group and the antibiotic control group; the duodenal trypsin activity of different plant essential oil preparation groups was significantly higher than that of the non-antibiotic control group, with the highest activity in the MCEO-1 group; the duodenal maltase activity of the MCEO-1 group was 17.5%, 19.7%, 5.2% and 6.9% higher than that of the non-antibiotic control group, the antibiotic control group, the MCEO-2 group and the MCEO-3 group, respectively; the duodenal lactase activity was 13.7%, 15.7% and 32.5% higher than that of the non-antibiotic control group, the antibiotic control group and the MCEO-3 group, respectively; the duodenal amylase activity was 41.5%, 29.0%, 12.5% ​​and 15.9% higher than that of the non-antibiotic control group, the antibiotic control group, the MCEO-2 group and the MCEO-3 group, respectively.

[0121] The activities of jejunal lipase and maltase in the MCEO-1 group were significantly higher than those in the non-antibiotic control group and the antibiotic control group; the jejunal sucrase activity of MCEO-1 was significantly higher than that in the other groups; the trypsin levels in the different preparations of plant essential oil groups were significantly higher than those in the non-antibiotic control group, and there was no significant difference with the antibiotic control group, with the highest trypsin activity in the MCEO-1 group; the jejunal amylase activity in the MCEO-1 group was significantly higher than that in the non-antibiotic control group, the antibiotic control group and the MCEO-2 group; the jejunal lactase activity in the MCEO-1 group was increased by 46.9%, 24.7%, 3.9% and 16.4% compared with the non-antibiotic control group, the antibiotic control group, the MCEO-2 group and the MCEO-3 group, respectively.

[0122] 14. Intestinal inflammatory factors

[0123] The results of the determination of intestinal inflammatory factors are shown in Table 15.

[0124] Table 15 Effects of different treatments on the relative expression of intestinal inflammatory factors in weaned piglets

[0125] Items Control group Antibiotic group MCEO-1 MCEO-2 MCEO-3 Duodenum Tumor necrosis factor α TNFα 1.00 0.79 0.63 0.87 0.85 Interleukin-4 <![CDATA[1.00 c ]]> <![CDATA[1.64 b ]]> <![CDATA[2.50 a ]]> <![CDATA[1.87 ab ]]> <![CDATA[1.52 b ]]> Interleukin-1βIL-1β <![CDATA[1.00 a ]]> <![CDATA[0.68 b ]]> <![CDATA[0.59 b ]]> <![CDATA[0.70 b ]]> <![CDATA[0.76 b ]]> Interleukin 10IL-10 <![CDATA[1.00 b ]]> <![CDATA[1.46 ab ]]> <![CDATA[2.02 a ]]> <![CDATA[1.99 a ]]> <![CDATA[1.47 ab ]]> Interferon gamma IFNγ 1.00 0.65 0.68 0.81 0.74 jejunum Tumor necrosis factor α TNFα <![CDATA[1.00 a ]]> <![CDATA[0.46 b ]]> <![CDATA[0.69 b ]]> <![CDATA[0.77 b ]]> <![CDATA[0.78 b ]]> Interleukin-4 <![CDATA[1.00 b ]]> <![CDATA[0.40 b ]]> <![CDATA[2.10 a ]]> <![CDATA[1.64 a ]]> <![CDATA[1.72 a ]]> Interleukin-1βIL-1β <![CDATA[1.00 a ]]> <![CDATA[0.88 a ]]> <![CDATA[0.63 b ]]> <![CDATA[0.79 b ]]> <![CDATA[0.83 ab ]]> Interleukin 10IL-10 <![CDATA[1.00 b ]]> <![CDATA[1.48 b ]]> <![CDATA[2.25 a ]]> <![CDATA[1.33 b ]]> <![CDATA[1.06 b ]]> Interferon gamma IFNγ <![CDATA[1.00 a ]]> <![CDATA[1.73 a ]]> <![CDATA[0.24 b ]]> <![CDATA[0.40 b ]]> <![CDATA[0.98 ab ]]> Ileum Tumor necrosis factor α TNFα <![CDATA[1.00 a ]]> <![CDATA[0.59 b ]]> <![CDATA[0.62 b ]]> <![CDATA[0.68 ab ]]> <![CDATA[0.75 ab ]]> Interleukin-4 <![CDATA[1.00 b ]]> <![CDATA[1.19 b ]]> <![CDATA[1.69 a ]]> <![CDATA[1.88 a ]]> <![CDATA[1.30 a ]]> Interleukin-1βIL-1β <![CDATA[1.00 a ]]> <![CDATA[0.22 b ]]> <![CDATA[0.56 ab ]]> <![CDATA[0.99 a ]]> <![CDATA[0.84 ab ]]> Interleukin 10IL-10 <![CDATA[1.00 b ]]> <![CDATA[1.29 a ]]> <![CDATA[1.65 a ]]> <![CDATA[1.48 a ]]> <![CDATA[1.07 b ]]> Interferon gamma IFNγ <![CDATA[1.00 a ]]> <![CDATA[0.86 ab ]]> <![CDATA[0.58 b ]]> <![CDATA[0.90 a ]]> <![CDATA[0.85 ab ]]>

[0126] As can be seen from Table 15, MCEO-1 significantly upregulated the expression of IL-4, MCEO-1 and MCEO-3 significantly upregulated the relative expression of IL-10 in the duodenum, and the relative expression of IL-1β in the duodenum of piglets in the MCEO-1 group was significantly lower than that in piglets in the PC, MCEO-3 and MCEO-2 groups; MCEO-1 significantly upregulated the relative expression of TNFα, IL-4, IL-10 and IL-1β in the jejunum of piglets, and MCEO-1 and MCEO-3 significantly upregulated the expression of IFNγ in the jejunum of piglets. The relative expression of TNFα in the ileum of piglets in the MCEO-1 and MCEO-2 groups was significantly higher than that in the PC group. Compared with the PC group, all essential oil groups significantly increased the relative expression of IL-4 in the ileum, MCEO-1 and MCEO-2 significantly increased the relative expression of IL-1β in the ileum, MCEO-2 significantly increased the relative expression of IL-10, and the relative expression of IFNγ in the ileum of piglets in the MCEO-1 group was significantly higher than that in the NC group. Different plant essential oil preparations had no significant regulatory effect on the expression of ileal inflammatory factors. The results in Table 15 show that MCEO-1 upregulated intestinal anti-inflammatory factors to a certain extent and downregulated the expression of pro-inflammatory factors, which is consistent with the results of inflammatory factors in serum, indicating that MCEO-1 can regulate the gastrointestinal immune system of weaned piglets by stimulating immune cells to secrete inflammatory factors, so that the intestine of weaned piglets is in a balanced and controllable inflammatory state.

[0127] In summary, plant essential oils can reduce the stress response caused by weaning in piglets to a certain extent, reduce the endotoxin content in serum and intestines, improve the growth and metabolic intensity of piglets, and enhance the body's immune capacity; plant essential oils can improve the morphological structure of the small intestine, enhance the tight connection function of the intestinal mucosa, reduce the intestinal permeability of piglets to a certain extent, and maintain the normal physical barrier function of the small intestine. Plant essential oils can maintain intestinal acidity, increase the activity of intestinal digestive enzymes, enhance the body's digestion and absorption capacity, improve intestinal immunity, and promote the balance of intestinal microecological environment. Under the same additive dosage conditions, MCEO-1 is better than MCEO-2 and MCEO-3, and has the effects of reducing the feed-to-meat ratio and diarrhea rate of weaned piglets, improving the body's immunity and antioxidant properties, and improving intestinal health. The preparation process of pre-packaging with dextrin + starch and adding shellac flakes to hydrogenated vegetable oil for outer packaging improves the effect of plant essential oil sustained-release microcapsules, which has broad application prospects.

[0128] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A feed additive for improving the production performance of weaned piglets, characterized in that: The dosage form is microcapsule; Calculated by mass percentage, the components include: capsule core material: 10-15% plant essential oil, capsule wall material: inner layer: 15-20% dextrin and 25-30% starch, outer layer: 25-30% hydrogenated vegetable oil and 15-20% shellac flakes.

2. The feed additive for improving the production performance of weaned piglets according to claim 1, characterized in that: The thymol in the plant essential oil is ≥13.5wt.%, and the cinnamaldehyde is ≥6.5wt.%.

3. A method for preparing a feed additive for improving the production performance of weaned piglets according to claim 1 or 2, characterized in that the steps include: Dissolve dextrin and starch in water, add plant essential oil, disperse them to form an oil-in-water coating structure, homogenize them, and then perform preliminary spray drying to obtain pre-encapsulated microcapsules; mix hydrogenated vegetable oil and shellac flakes and heat and melt them, spray the pre-encapsulated microcapsules from an upper normal temperature nozzle to a low-temperature drying chamber, and then spray the molten mixture of hydrogenated vegetable oil and shellac flakes to the low-temperature drying chamber from a heated nozzle below the normal temperature nozzle, mix them evenly under the action of airflow to form solid microcapsules, and sieve them to obtain a feed additive for improving the production performance of weaned piglets.

4. The preparation method according to claim 3, characterized in that: The heating and melting temperature is 80-85°C.

5. The preparation method according to claim 3, characterized in that: The sieving is through a 20-mesh sieve.

6. Use of the feed additive for improving the production performance of weaned piglets according to claim 1 or 2 in feed additives for weaned piglets.

Citation Information

Patent Citations

  • Acid and essential oil composite preparation and preparation method thereof

    CN107156455A

  • Nanometer coated plant essential oil for suckling piglets and preparation method thereof

    CN109549001A

  • Plant essential oil inclusion compound and preparation method thereof

    CN112450324A

  • Animal feed additive and animal feed

    CN112533486A

  • Coated plant essential oil for piglets and preparation method of coated plant essential oil

    CN112544808A

Cited By

  • Application of borneol essential oil in promoting growth performance of piglets

    CN120604755A